DOCUMENTS

bibliography

Peri‐complication diagnosis of hepatitis C infection: Risk factors and trends over time

Published: September 21, 2020
Category: Bibliography
Authors: Beate Sander, Hannah Chung, Jeffrey C. Kwong, Jordan J. Feld, Laura Holder, Lauren Lapointe‐Shaw, Orlando Cerocchi, Peter C. Austin
Countries: Canada
Language: English
Types: Population Health
Settings: Hospital, PCP

Abstract

Background & Aims

Hepatitis C virus (HCV) is a common and treatable cause of cirrhosis and its complications, yet many chronically infected individuals remain undiagnosed until a late stage. We sought to identify the frequency of and risk factors for HCV diagnosis peri‐complication, that is within six months of an advanced liver disease complication.

Methods

This was a retrospective cohort study of Ontario residents diagnosed with chronic HCV infection between 2003 and 2014. HCV diagnosis peri‐complication was defined as the occurrence of decompensated cirrhosis, hepatocellular carcinoma or liver transplant within ±6 months of HCV diagnosis. Multivariable logistic regression was used to identify risk factors for peri‐complication diagnosis among all those diagnosed with HCV infection.

Results

Our cohort included 39,515 patients with chronic HCV infection, of whom 4.2% (n = 1645) were diagnosed peri‐complication; these represented 31.6% of the 5,202 patients who developed complications in the follow‐up period. Peri‐complication diagnosis became more common over the study period and was associated with increasing age among baby boomers, alcohol use, diabetes mellitus, chronic HBV co‐infection and moderate to high levels of morbidity. Female sex, immigrant status, having more previous outpatient physician visits, a previous emergency department visit, a history of drug use or mental health visits were associated with reduced risk of peri‐complication diagnosis.

Conclusions

Over a quarter of HCV‐infected patients with complications were diagnosed peri‐complication. This problem increased over time, suggesting a need to further expand HCV screening.

HCV,cirrhosis,viral hepatitis,temporal trends,screening

Please log in/register to access.

Log in/Register

LinkedIn Facebook Twitter

© The Johns Hopkins University, The Johns Hopkins Hospital, and Johns Hopkins Health System.
All rights reserved. Terms of Use Privacy Statement

Back to top